Administration of atosiban in patients with endometriosis undergoing frozen-thawed embryo transfer: a prospective, randomized study

Ye He, He Y, Wu H, Huan Wu, He X, Xiaojin He, Qiong Xing, Xing Q, Zhou P, Ping Zhou, Yunxia Cao, Cao Y, Wei Z, Zhaolian Wei
Fertility and sterility · 2016 · vol. 106(2) , pp. 416–422 · doi:10.1016/j.fertnstert.2016.04.019 · PMID:27143518 · W2342599690
RCT OA: bronze CC0 ⤵ 23 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

This prospective, randomized study investigated the effect of atosiban administration on pregnancy and implantation rates in patients with endometriosis undergoing frozen-thawed embryo transfer.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To examine the effects of atosiban, given before transfer of frozen-thawed embryo to women with endometriosis (EMs). DESIGN: A randomized, controlled clinical trial. SETTING: University hospital and IVF center. PATIENT(S): One hundred twenty women with endometriosis undergoing frozen-thawed embryo transfer were randomly allocated into the atosiban treatment and the control groups. Another 120 women with infertility due to tubal factor were enrolled into a tubal factor group, to compare serum oxytocin (OT) and prostaglandin (PG)F2α levels and uterine contractions with the endometriosis group. INTERVENTION(S): In the endometriosis treatment group, a single bolus (6.75 mg, 0.9 mL per vial) of atosiban was administrated before ET. MAIN OUTCOME MEASURE(S): Implantation rate and pregnancy rate. RESULT(S): Serum OT level (1.89 ± 0.33 vs. 1.66 ± 0.32 ng/L), PGF2α (2.83 ± 0.34 vs. 2.36 ± 0.35 ng/L) level, and uterine contractions (2.5 ± 1.2 vs. 1.8 ± 1.0 waves per minute) in the endometriosis group were all significantly higher than in the tubal factor group. The clinical pregnancy rate per cycle and implantation rate per transfer were 58.3% and 41.0%, respectively, in the atosiban treatment group, significantly higher than in the control group (38.3% and 23.4%, respectively). CONCLUSION(S): Women with endometriosis showed higher serum OT level, PGF2α level, and uterine contractions. Atosiban treatment before ET in endometriosis is effective in the priming of the uterus, suitable for embryo implantation. This is the first study to evaluate the effect of atosiban treatment in patients with endometriosis. CLINICAL TRIAL REGISTRATION NUMBER: ChiCTR-IOQ-14005715.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Cryopreservation Cryopreservation Embryo Transfer Embryo Transfer Embryo Transfer Endometriosis Fertilization in Vitro Fertilization in Vitro Fertilization in Vitro Hormone Antagonists Infertility, Female Vasotocin Adult Adult Biomarkers Biomarkers Biomarkers China China Dinoprost

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (48)

Cited by (23)

Source provenance

europepmc
last seen: 2026-10-13T06:10:10.580696+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:17:40.612859+00:00
License: CC0 · commercial use OK